Clinical Trial

BOND: Direct Breastfeeding to Enhance Maternal and Infant Health in Congenital Heart Disease

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The primary objective of this study is to enhance the rates of direct breast feeding (DBF) among infants with congenital heart disease (CHD), and to gain insights into the implications of DBF on key metrics of child and parent well-being. A multicenter parallel cluster platform design will be employed. The intervention will be a multifaceted approach to enhance direct breastfeeding. Participating sites will be randomized into either intervention (strategies to enhance direct breastfeeding) or conventional care.
Trial Details
NCT Number NCT07582848
Lead Sponsor Carelon Research
Conditions Congenital Heart Disease (CHD)
Enrollment 266 participants
Start Date 2026-04
Primary Completion 2029-04 (estimated)
Study Completion 2030-06 (estimated)
Updated on ClinicalTrials.gov 2026-05-13